Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|5|4|445-452

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.5, Iss.4, 2006-01, pp. : 445-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological profile of YM348, a novel, potent and orally active 5-HT 2C receptor agonist

By Kimura Y.   Hatanaka K.-i.   Naitou Y.   Maeno K.   Shimada I.   Koakutsu A.   Wanibuchi F.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 37-43

Elsevier

Access to resources Recommend Favorite

Atypical antipsychotics and inverse agonism at 5-HT2 receptors

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3732-3738

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the 5-HT2C Receptor in Atypical Antipsychotics: Hero or Villain?

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 1, 2005-03 ,pp. : 63-66

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological characterization of the 5-HT 1A , 5-HT 2 and 5-HT 3 receptors in the bovine ciliary muscle

By Lograno M.D.   Romano M.R.  

European Journal of Pharmacology, Vol. 464, Iss. 1, 2003-03 ,pp. : 69-74

Elsevier

Access to resources Recommend Favorite

Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors

By Knight Antony   Misra Anil   Quirk Kathleen   Benwell Karen   Revell Dean   Kennett Guy   Bickerdike Mike  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 114-123

Springer Publishing Company

Access to resources Recommend Favorite